{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:49:56Z","timestamp":1789429796337,"version":"build-2803163510"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1213\/01.ane.0000189554.41095.98","type":"journal-article","created":{"date-parts":[[2005,12,14]],"date-time":"2005-12-14T04:01:11Z","timestamp":1134532871000},"page":"225-232","source":"Crossref","is-referenced-by-count":63,"title":["Pretreatment with Simvastatin Reduces Lung Injury Related to Intestinal Ischemia-Reperfusion in Rats"],"prefix":"10.1213","volume":"102","author":[{"given":"Arash","family":"Pirat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Zeyneloglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Aldemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muammer","family":"Y\u00fccel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"\u00d6zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Candan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclnaz","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-38-20210902","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1056\/NEJM200005043421806","article-title":"The acute respiratory distress syndrome.","volume":"342","author":"Ware","year":"2000","journal-title":"N Engl J Med"},{"key":"R2-38-20210902","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1378\/chest.120.4.1347","article-title":"Treatment of ARDS.","volume":"120","author":"Brower","year":"2001","journal-title":"Chest"},{"key":"R3-38-20210902","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0163-7258(99)00045-5","article-title":"New insights into the pharmacodynamic and pharmacokinetic properties of statins.","volume":"84","author":"Corsini","year":"1999","journal-title":"Pharmacol Ther"},{"key":"R4-38-20210902","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jama.1997.03550040069040","article-title":"Cholesterol lowering with statin drugs, risk of stroke, and total mortality: an overview of randomized trials.","volume":"278","author":"Hebert","year":"1997","journal-title":"JAMA"},{"key":"R5-38-20210902","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.282.21.2043","article-title":"Preventing coronary artery disease by lowering cholesterol levels: fifty years from bench to bedside.","volume":"282","author":"Steinberg","year":"1999","journal-title":"JAMA"},{"key":"R6-38-20210902","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"R7-38-20210902","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2174\/1381612013397762","article-title":"Statins and bone formation.","volume":"7","author":"Garrett","year":"2001","journal-title":"Curr Pharm Des"},{"key":"R8-38-20210902","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1568-9972(03)00049-1","article-title":"Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins.","volume":"2","author":"Kwak","year":"2003","journal-title":"Autoimmun Rev"},{"key":"R9-38-20210902","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0165-6147(02)02077-1","article-title":"Statins as anti-inflammatory agents.","volume":"23","author":"Weitz-Schmidt","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"R10-38-20210902","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00041433-199912000-00010","article-title":"Low-density lipoprotein-independent effects of statins.","volume":"10","author":"Davignon","year":"1999","journal-title":"Curr Opin Lipidol"},{"key":"R11-38-20210902","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/1570161043385475","article-title":"Non-lipid effects of statins: emerging new indications.","volume":"2","author":"Yildirir","year":"2004","journal-title":"Curr Vasc Pharmacol"},{"key":"R12-38-20210902","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/01.ATV.21.1.115","article-title":"Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering.","volume":"21","author":"Sparrow","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R13-38-20210902","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.ATV.0000022694.16328.CC","article-title":"Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.","volume":"22","author":"Rezaie-Majd","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R14-38-20210902","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/01.ATV.0000043456.48735.20","article-title":"HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells.","volume":"23","author":"Dichtl","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R15-38-20210902","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1097\/01.CCM.0000057843.47705.E8","article-title":"Neutrophils and acute lung injury.","volume":"31","author":"Abraham","year":"2003","journal-title":"Crit Care Med"},{"key":"R16-38-20210902","doi-asserted-by":"crossref","first-page":"103S","DOI":"10.1378\/chest.116.suppl_1.103S","article-title":"Chemokines in lung injury: Thomas A. Neff Lecture.","volume":"116","author":"Strieter","year":"1999","journal-title":"Chest"},{"key":"R17-38-20210902","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0076-6879(78)52032-6","article-title":"Microsomal lipid peroxidation.","volume":"52","author":"Buege","year":"1978","journal-title":"Methods Enzymol"},{"key":"R18-38-20210902","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway.","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"R19-38-20210902","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1101\/gad.11.18.2295","article-title":"Pases and signaling networks.","volume":"11","author":"Van Aelst","year":"1997","journal-title":"Genes Dev"},{"key":"R20-38-20210902","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1161\/01.ATV.0000063385.12476.A7","article-title":"Endothelium-dependent effects of statins.","volume":"23","author":"Wolfrum","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R21-38-20210902","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1189\/jlb.68.5.593","article-title":"Cellular signaling in macrophage migration and chemotaxis.","volume":"68","author":"Jones","year":"2000","journal-title":"J Leukoc Biol"},{"key":"R22-38-20210902","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1161\/hq0801.094222","article-title":"In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products.","volume":"21","author":"Diomede","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R23-38-20210902","doi-asserted-by":"crossref","first-page":"33334","DOI":"10.1074\/jbc.274.47.33334","article-title":"Integrin-dependent leukocyte adhesion involves geranylgeranylated protein(s).","volume":"274","author":"Liu","year":"1999","journal-title":"J Biol Chem"},{"key":"R24-38-20210902","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0192-0561(96)00068-9","article-title":"Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line.","volume":"18","author":"Niwa","year":"1996","journal-title":"Int J Immunopharmacol"},{"key":"R25-38-20210902","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1185\/030079903125002225","article-title":"Early vascular benefits of statin therapy.","volume":"19","author":"Tsiara","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"R26-38-20210902","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0008-6363(03)00515-7","article-title":"Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.","volume":"59","author":"Mulhaupt","year":"2003","journal-title":"Cardiovasc Res"},{"key":"R27-38-20210902","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0022-5223(03)00699-8","article-title":"Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion.","volume":"126","author":"Naidu","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R28-38-20210902","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1053\/ejvs.2001.1318","article-title":"Pravastatin attenuates lower torso ischaemia-reperfusion-induced lung injury by upregulating constitutive endothelial nitric oxide synthase.","volume":"21","author":"Joyce","year":"2001","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R29-38-20210902","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0021-9150(02)00063-1","article-title":"Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes.","volume":"164","author":"Fuhrman","year":"2002","journal-title":"Atherosclerosis"},{"key":"R30-38-20210902","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1161\/01.CIR.0000091084.46500.BB","article-title":"Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment.","volume":"108","author":"Maack","year":"2003","journal-title":"Circulation"},{"key":"R31-38-20210902","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/01.HYP.37.6.1450","article-title":"HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.","volume":"37","author":"Wassmann","year":"2001","journal-title":"Hypertension"},{"key":"R32-38-20210902","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/10623320303357","article-title":"Interrelationship of free oxygen radicals and endothelial dysfunction\u2013modulation by statins.","volume":"10","author":"Wassmann","year":"2003","journal-title":"Endothelium"},{"key":"R33-38-20210902","doi-asserted-by":"crossref","first-page":"13422","DOI":"10.1074\/jbc.271.23.13422","article-title":"Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB, and glutathione S-transferase gene expression.","volume":"271","author":"Pinkus","year":"1996","journal-title":"J Biol Chem"},{"key":"R34-38-20210902","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1164\/ajrccm.156.4.9702095","article-title":"Interleukin-1 in ischemia-reperfusion acute lung injury.","volume":"156","author":"Chang","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"R35-38-20210902","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0021-9150(99)00193-8","article-title":"Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells.","volume":"147","author":"Ortego","year":"1999","journal-title":"Atherosclerosis"},{"key":"R36-38-20210902","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1007\/s00134-004-2370-x","article-title":"Pulmonary endothelium in acute lung injury: from basic science to the critically ill.","volume":"30","author":"Orfanos","year":"2004","journal-title":"Intensive Care Med"},{"key":"R37-38-20210902","doi-asserted-by":"crossref","first-page":"L3","DOI":"10.1152\/ajplung.00405.2003","article-title":"Chemokines in acute respiratory distress syndrome.","volume":"288","author":"Puneet","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/01.ane.0000189554.41095.98","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:06:04Z","timestamp":1786111564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-200601000-00038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1213\/01.ane.0000189554.41095.98","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}